Yashwant Chaudhri

Mental HealthVerified

About

Dr. Yashwant Chaudhri, MD operates a psychiatry practice in College Area from 4537 College Ave, San Diego, CA 92115, inside the medical office building half a mile south of SDSU. Board-certified in psychiatry with NPI 1043258429, Dr. Chaudhri completed his medical education at Government Medical College in India before finishing residencies in both psychiatry and neurology at the University of Rochester and St. Elizabeth's Medical Center. That dual residency background informs a diagnostic approach to major depressive disorder, bipolar disorder, schizoaffective disorder, and anxiety, which represent the core of his caseload across more than four decades of practice since 1981. The College Avenue office draws referrals from campus-adjacent primary care providers, including SDSU Student Health Services, for students requiring psychiatric evaluation beyond the scope of a general health visit. Dr. Chaudhri holds an affiliation with Scripps Mercy Hospital San Diego, allowing inpatient psychiatric coordination when outpatient management alone is insufficient. His practice extends to child and adolescent psychiatry, covering early-onset mood and psychotic-spectrum conditions that require developmental staging in medication selection. Consultations are conducted in both English and Hindi, reflecting the multilingual patient base along the El Cajon Blvd and College Avenue corridors in the 92115 ZIP. Through his CalTMS division, Dr. Chaudhri offers Transcranial Magnetic Stimulation for patients with treatment-resistant major depressive disorder and obsessive-compulsive disorder who have not responded to standard pharmacotherapy, a protocol that supplements the talk-therapy and medication-management approaches at outpatient behavioral health practices such as Alter Behavioral Health - San Diego in the same College Area corridor. Common prescriptions from the practice include quetiapine fumarate, risperidone, and divalproex sodium ER, alongside long-acting injectable paliperidone palmitate administered on-site for patients requiring sustained antipsychotic coverage between office visits.